Clinical trials
Shock clinical trials
Below are recruiting shock clinical trials, each written for real people, not researchers. We’re tracking 313 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06688344Recruiting
Shock wave therapy after ACL surgery
This trial tests if adding focused shock wave therapy to standard rehab can improve recovery after ACL reconstruction using a hamstring graft. It may help reduce pain and speed up healing.
IstanbulAges 18–45 - NCT05093075RecruitingPhase 2
Plasma exchange for ICU patients with severe septic shock
This study tests whether therapeutic plasma exchange (a procedure that removes and replaces blood plasma) can improve outcomes in ICU patients with septic shock that is not responding to standard medicines. It may help some people whose infection-related illness is causing failing organs.
Calgary, AlbertaAges 16 years+ - NCT06638268Recruiting
TAVI for severe aortic stenosis in cardiogenic shock
This study tests whether a procedure called TAVI (a valve replacement done through a tube in the leg) can help people with severe aortic stenosis who are in cardiogenic shock, a dangerous condition where the heart can't pump enough blood. The goal is to see if urgent valve replacement improves survival.
Copenhagen OAges Any age - NCT05985525Recruiting
Monitoring blood flow in ICU patients with severe infection or shock
This study monitors tiny blood vessels under the tongue using a non-invasive device to see how well blood flows in ICU patients on a breathing machine. Researchers hope to improve care for patients with serious infections or shock.
Winnipeg, ManitobaAges 18 years+ - NCT06572826Recruiting
Cardiac rehab after cardiogenic shock recovery
This study looks at whether a cardiac rehab program (exercise and education) can help people recover after being treated for cardiogenic shock, a life-threatening condition where the heart suddenly can't pump enough blood.
MilanAges 18–110 - NCT06569615Recruiting
Comparing shock wave, laser, and cold therapy for sacroiliitis pain
This trial compares three different treatments (shock wave therapy, laser therapy, and cold therapy) for people with sacroiliitis, a condition that causes pain in the lower back, buttocks, or hips. The goal is to see which treatment works best for reducing pain and improving movement.
Najran, Najran RegionAges 20–50 - NCT06539234Recruiting
Angiotensin II test for treating vasoplegic shock
This trial tests a medicine called angiotensin II to see how well it helps people whose blood pressure stays dangerously low after standard treatments for vasoplegic shock, a condition where blood vessels relax too much. If it works, it might help raise blood pressure and improve blood flow to vital organs.
MariborAges 18 years+ - NCT06500156Recruiting
Metabolic patterns in septic shock patients
This study looks at how the body uses energy (metabolism) in people with septic shock. It collects information from standard monitoring during a fluid challenge (a small IV fluid test) to find patterns that might help doctors better understand and treat septic shock.
Sabadell, BarcelonaAges 18 years+ - NCT06491745Recruiting
Shock wave therapy for frozen shoulder
This study tests whether adding shock wave therapy to standard treatments (physical therapy and a corticosteroid injection) helps people with frozen shoulder recover faster. If you have significant shoulder stiffness and pain, you might benefit from this extra treatment.
TaipeiAges 20–80 - NCT06460519Recruiting
Comparing wrist and groin blood pressure in shock patients
This study looks at how blood pressure readings differ between the wrist and the groin in people with severe low blood pressure (shock) who are not recovering from heart surgery. It aims to help doctors better understand and treat shock by comparing these two measurements.
BronAges 18–99 - NCT05146336Recruiting
CytoSorb registry for critically ill patients needing blood treatment
This registry collects information about critically ill patients who receive the CytoSorb 300 mL blood treatment. It may help doctors better understand when the treatment works best and when it should not be used.
KlagenfurtAges Any age - NCT06320509Recruiting
Using urine oxygen to predict kidney recovery in shock
This study is testing if measuring oxygen levels in urine can help predict when kidney injury starts or gets better in ICU patients with shock. It aims to guide treatment earlier and avoid kidney damage.
AngersAges 18 years+ - NCT06296017Recruiting
Comparing nonsurgical treatments for trigger finger
This study compares nonsurgical treatments (like exercises, splints, or injections) for trigger finger. It aims to find which conservative approach works best for mild cases without surgery.
AnkaraAges 18–65 - NCT06140147Recruiting
Reducing fluids in septic shock care
This study tests if giving fewer fluids (other than the fluids to keep blood pressure up) can help people recover from septic shock. It compares a reduced fluid strategy to the usual care in the ICU.
HelsinkiAges 18 years+ - NCT05485376Recruiting
Pulmonary artery catheter use in cardiogenic shock patients
This trial studies whether using a special pressure-monitoring tube in the heart’s main artery (a pulmonary artery catheter) helps people who are in cardiogenic shock from weak heart pumping. If you qualify, the goal is to improve how doctors monitor and treat this dangerous, fast-moving condition.
Boston, MassachusettsAges 18–90 - NCT03401398RecruitingPhase 3
Hydrocortisone for children with septic shock in the ICU
This Phase 3 trial tests whether giving stress-dose hydrocortisone can improve outcomes for children with septic shock in the pediatric intensive care unit (PICU). It is designed for children who are already receiving strong medicines to support blood pressure because of a serious infection.
Tucson, ArizonaAges 1 month–17 years - NCT02880163Recruiting
Test foam used to stop dangerous internal abdominal bleeding
This trial tests whether an expandable foam can quickly help slow or control life-threatening bleeding inside the belly. It is designed for emergency situations where surgery to stop the bleeding will happen soon.
Birmingham, AlabamaAges 15 years+ - NCT06041958Recruiting
Shock Wave and Pulsed Field Therapy for Lymphedema
This trial tests two non-invasive therapies—shock wave therapy and pulsed electromagnetic field therapy—to see if they can reduce arm or leg swelling (lymphedema) caused by cancer treatment. It's for people who are at least 20 and have had breast or gynecologic cancer.
Kaohsiung CityAges 20–80 - NCT05728359Recruiting
Genetic study of outcomes in cardiogenic shock
This study looks at whether a person’s genetic information (genomics) can help predict outcomes in cardiogenic shock. You may be asked to give consent and provide information during a serious heart-related emergency, usually soon after symptoms start.
LondonAges 18–80 - NCT05956418RecruitingPhase 4
Testing centhaquine for low-blood-pressure shock patients
This trial studies whether centhaquine is safe and can help treat adults in the emergency room or ICU who have hypovolemic shock (dangerously low blood pressure from low circulating fluid). Participants receive the usual shock care, and the study adds this medicine to see if outcomes improve.
Nellore, Andhra PradeshAges 18 years+ - NCT05928767Recruiting
Using frailty scores to predict death in ICU sepsis
This trial checks whether a “frailty” rating (how physically/mentally vulnerable someone is) can predict the risk of death in ICU patients with sepsis shock. It may help doctors identify higher-risk patients earlier and tailor care.
BéthuneAges 18–65 - NCT05888974Recruiting
Test of heart ultrasound to guide fluids in shock
This study checks whether a specific heart ultrasound measurement can help doctors decide if you will benefit from extra fluid during early emergency treatment for shock. It may help avoid unnecessary fluids and support faster, safer decision-making.
NîmesAges 18 years+ - NCT05383963Recruiting
Using ICU routine data to diagnose sepsis sooner
This study checks whether information collected routinely in the ICU can help doctors recognize sepsis or septic shock earlier. If it works, it may improve how quickly diagnosis happens and potentially outcomes for patients.
BerlinAges 18 years+ - NCT05700617RecruitingEarly Phase 1
Testing cardiac pumping strength in cardiogenic shock
This early study looks at how well the heart is pumping in people with cardiogenic shock, using measurements taken during a right-heart catheter (a small pressure-monitoring test). It may help doctors better assess heart function and guide next-step treatments like LVAD, heart transplant, or valve surgery.
Chicago, IllinoisAges 18 years+
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for shock?
- Yes. Clin2 currently lists 313 recruiting shock studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a shock trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a shock trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.